Search bioRxiv⌕ Search

Biology subjects

Yavari, B.

Publications and source records attributed to Yavari, B..

2 recordsLinked to original sources

Does Fermentation Enhance Beverage Safety? Kombucha's Resistance to Microbial Invasion Suggests a Protective Role

Does fermentation enhance the safety of beverages? This study investigates kombuchas resilience to microbial invasion from human hands. Kombucha, an ancient fermented tea, relies on a biofilm known as a symbiotic community of bacteria and yeast (SCOBY) and a starter culture to ferment sweet tea, producing various metabolites including gluconic acid, acetic acid, ethanol, and carbon dioxide. While fermented foods have been historically associated with potential health benefits, direct evidence comparing the prevalence of human pathogens in fermented versus non-fermented beverages has been lacking. To address this, we conducted a citizen science experiment at Arizona State University, introducing swabs from peoples palms into both kombucha and a sweet tea control. Over 30 days, we monitored the bacterial and fungal composition using 16S and ITS rRNA sequencing. Our findings reveal that kombucha maintained a relatively stable microbial profile and physical appearance, with a typical SCOBY biofilm developing. In stark contrast, the sweet tea experienced a dramatic change in microbial composition and was visibly compromised by rapidly growing microorganisms. Importantly, this suggests that the complex microbial ecosystem of kombucha can limit the growth of foreign microbes introduced from human hands. Given that human pathogens were absent from the kombucha while present in the tea samples, our results indicate that the antimicrobial properties of fermentation byproducts and the physical barrier of the SCOBY may contribute to this resilience. Further research is warranted to fully elucidate the mechanisms underlying kombuchas resistance to microbial invasion.

microbiology↗

Leveraging Comparative Phylogenetics for Evolutionary Medicine: Applications to Comparative Oncology

Comparative phylogenetics provides a wealth of computational tools to understand evolutionary processes and their outcomes. Advances in these methodologies have occurred in parallel with a surge in cross-species genomic and phenotypic data. To date, however, the majority of published studies have focused on classical questions in evolutionary biology, such as speciation and the ecological drivers of trait evolution. Here, we argue that evolutionary medicine in general, and our understanding of the origin and diversification of disease traits in particular, would be greatly expanded by a wider integration of phylogenetic comparative methods (PCMs). We use comparative oncology - the study of cancer across the tree of life - as a case study to demonstrate the power of the approach and show that implementing PCMs can highlight the mode and tempo of the evolutionary changes in intrinsic, species-level disease vulnerabilities.

evolutionary biology↗